A detailed history of Signet Investment Advisory Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Signet Investment Advisory Group, Inc. holds 3,819 shares of LLY stock, worth $3.01 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares
3,819
Previous 7,434 48.63%
Holding current value
$3.01 Million
Previous $6.73 Million 49.73%
% of portfolio
1.69%
Previous 3.61%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$772.14 - $960.02 $2.79 Million - $3.47 Million
-3,615 Reduced 48.63%
3,819 $3.38 Million
Q2 2024

Jul 19, 2024

SELL
$724.87 - $909.04 $28,994 - $36,361
-40 Reduced 0.54%
7,434 $6.73 Million
Q1 2024

Apr 29, 2024

SELL
$592.2 - $792.28 $106,596 - $142,610
-180 Reduced 2.35%
7,474 $5.81 Million
Q4 2023

Jan 25, 2024

SELL
$525.19 - $619.13 $42,540 - $50,149
-81 Reduced 1.05%
7,654 $4.46 Million
Q3 2023

Oct 20, 2023

SELL
$434.7 - $599.3 $66,074 - $91,093
-152 Reduced 1.93%
7,735 $4.15 Million
Q2 2023

Jul 19, 2023

SELL
$350.74 - $468.98 $148,363 - $198,378
-423 Reduced 5.09%
7,887 $3.7 Million
Q1 2023

May 09, 2023

SELL
$310.63 - $364.82 $46,905 - $55,087
-151 Reduced 1.78%
8,310 $2.85 Million
Q4 2022

Jan 20, 2023

SELL
$321.55 - $374.67 $144,697 - $168,601
-450 Reduced 5.05%
8,461 $0
Q3 2022

Oct 20, 2022

SELL
$296.48 - $337.87 $221,767 - $252,726
-748 Reduced 7.74%
8,911 $2.88 Million
Q2 2022

Aug 03, 2022

SELL
$278.73 - $327.27 $218,524 - $256,579
-784 Reduced 7.51%
9,659 $3.13 Million
Q1 2022

May 03, 2022

SELL
$234.69 - $291.66 $434,645 - $540,154
-1,852 Reduced 15.06%
10,443 $2.99 Million
Q4 2021

Jan 27, 2022

SELL
$224.85 - $279.04 $36,650 - $45,483
-163 Reduced 1.31%
12,295 $3.4 Million
Q3 2021

Nov 09, 2021

SELL
$221.6 - $272.71 $111,243 - $136,900
-502 Reduced 3.87%
12,458 $2.88 Million
Q2 2021

Jul 26, 2021

SELL
$180.55 - $233.54 $131,440 - $170,017
-728 Reduced 5.32%
12,960 $2.98 Million
Q1 2021

May 11, 2021

SELL
$164.32 - $212.72 $59,155 - $76,579
-360 Reduced 2.56%
13,688 $2.56 Million
Q4 2020

Feb 05, 2021

SELL
$130.46 - $172.63 $134,634 - $178,154
-1,032 Reduced 6.84%
14,048 $2.37 Million
Q4 2019

Feb 10, 2020

SELL
$106.92 - $132.43 $4,811 - $5,959
-45 Reduced 0.3%
15,080 $1.98 Million
Q3 2019

Nov 06, 2019

SELL
$106.79 - $116.16 $13,348 - $14,520
-125 Reduced 0.82%
15,125 $1.69 Million
Q2 2019

Aug 06, 2019

SELL
$110.79 - $129.32 $29,802 - $34,787
-269 Reduced 1.73%
15,250 $1.69 Million
Q1 2019

May 06, 2019

SELL
$111.31 - $131.02 $32,279 - $37,995
-290 Reduced 1.83%
15,519 $2.01 Million
Q4 2018

Jan 31, 2019

BUY
$105.9 - $118.64 $1.67 Million - $1.88 Million
15,809 New
15,809 $1.83 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Signet Investment Advisory Group, Inc. Portfolio

Follow Signet Investment Advisory Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signet Investment Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Signet Investment Advisory Group, Inc. with notifications on news.